Xuezhong Gu

Xuezhong Gu

Auto-generated profile, based on publicly available information

Xuezhong Gu

Department of Hematology, The First People’s Hospital of Yunnan Province, Yunnan Province Clinical Research Center for Hematologic Disease, Yunnan Province Clinical Center for Hematologic Disease, Kunming, 650032 Yunnan, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2023 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
HZHaixi Zhang
Haixi Zhang
JZJie Zhao
Jie Zhao
ACArunachalam Chinnathambi
Arunachalam Chinnathambi
VMVelmurugan Meganathan
Velmurugan Meganathan
XGXuezhong Gu
Xuezhong Gu

1 February 2019 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
ZSZhenglei Shen
Zhenglei Shen
XGXuezhong Gu
Xuezhong Gu
WMWenwen Mao
Wenwen Mao
HCHonghua Cao
Honghua Cao
RZRui Zhang
Rui Zhang
LYLiefen Yin
Liefen Yin
Background: Leukemia is a hematological malignancy characterized by the proliferation of early lymphoid precursors that replaces normal hematopoietic cells of the bone marrow. Nakhi (Naxi) ethnic minorities considered to be an area of low incidence. MicroRNAs (miRNAs) are a class of small noncoding RNAs that regulate the expression of other genes in various biological processes. The purpose of this work is to study the molecular mechanism of miRNAs in the leukemia from Naxi. Methods: Six leukemia patients (case 2 to case 7) and one healthy person (case 1) from Nakhi (Naxi) ethnic minorities were recruited. Total RNA was extracted from these samples and small RNA deep sequencing was performed. Results: A list of miRNAs (1,392 known and candidate 125 novels) expressed in leukocytes were identified, and many differentially regulated targets involved in several cellular pathways, such as cancer, Rap1 signaling pathway, Ras signaling pathway, and endocytosis. Additionally, quantitative real time-polymerase chain reaction (qRT-PCR) results show that hsa-miR-181b-5p, hsa-miR-181a-3p, hsa-miR-181a-5p, and hsa-miR-342-3p has different expression patterns in different cancer cells, hsa-miR-450a-5p, and hsa-miR-1255a were dysregulated in all leukemia cells. Conclusions: Several abnormal expressed miRNAs in leukemia patients were identified, the correlation of miRNAs dysregulation and leukemia biology demonstrates that specific miRNA can be potential therapeutic target.

8 March 2024 in Medicine
Verified
Journal Article
Open access
FLFen Mm Li
Fen Mm Li
JZJie Mm Zhao
Jie Mm Zhao
HDHuanan Mm Duan
Huanan Mm Duan
HZHaixi Mm Zhang
Haixi Mm Zhang
LZLin Mm Zhang
Lin Mm Zhang
XGXuezhong Mm Gu
Xuezhong Mm Gu
Introduction: Pyoderma gangrenosum (PG) is a rare noninfectious neutrophilic skin disease. The diagnosis of PG is mainly based on clinical manifestations. Therefore, the clinical features of PG are important for confirming the diagnosis of this disease. Herein, the clinical data of 2 young males with PG complicated with hematological malignancies were reported, and the literature were reviewed. Case presentation: The first case was a 22-year-old male who was admitted due to a systemic rash, headache, and fever. Physical examination showed black scabs on the skins of the extremities, trunk, scalp, and face. Biopsy of the skin lesion showed epidermal edema, spongy formation, neutrophil infiltration, acute and chronic inflammatory cell infiltration in the dermis, showing purulent inflammation with epidermal erosion. The bone marrow biopsy showed obviously active proliferation of nucleated cells, granulocytes at various stages, abnormal morphological neutrophils, and occasionally observed young red blood cells. The diagnosis of PG and chronic myelomonocytic leukemia (CMML-0) was made. The second case was a 28-year-old male who presented a swollen, painful right calf following injury and then developed ulcers on skin and soft tissues. Bone marrow biopsy showed obviously active nucleated cell proliferation, suggesting a myeloid tumor. He was also diagnosed with PG and hematological malignancies. They both received hormone and antiinfection therapy. After treatment, their body temperature, infection, and skin lesions were improved. However, both of them were readmitted and had a poor prognosis. Conclusions: PG may be associated with hematological malignancies. For patients with typical skin lesions and obvious abnormal blood routines, it is necessary to investigate the possibility of PG with hematological malignancies.

14 January 2026 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
LFLi Fen
Li Fen
DNDuan Hua Nan
Duan Hua Nan
YNYu Lin Na
Yu Lin Na
ZJZhao Jie
Zhao Jie
GZGu Xue Zhong
Gu Xue Zhong
Background: Hemophagocytic lymphohistiocytosis (HLH) is a severe inflammatory disorder caused by excessive immune activation. This exploratory study aimed to systematically identify potential diagnostic key genes linked to iron metabolism during HLH progression using comprehensive bioinformatics analysis and explore the underlying mechanisms. Methods: Thirty peripheral blood mononuclear cell (PBMC) samples—15 from patients with HLH and 15 controls—were analyzed through mRNA sequencing. Total RNA was extracted from these samples. First, the overlap between differentially expressed genes (DEGs) and iron metabolism-related genes (FeRGs) was identified to select candidate genes. Key genes were then derived using the Boruta method and least absolute shrinkage and selection operator (LASSO) regression analysis. Further investigations, including correlation, functional, and enrichment analyses, as well as immune infiltration and drug prediction, were performed to explore the molecular mechanisms. Finally, reverse transcription quantitative PCR (RT-qPCR) was used to validate the expression levels of the key genes in clinical specimens. Results: The intersection of 464 DEGs and 520 FeRGs identified 10 candidate genes. Machine learning analysis identified ALOX15, CAT, HBZ, MT2A, and CYGB as HLH key genes. A significant positive correlation was observed between ALOX15 and HBZ, while ALOX15 showed a notable negative correlation with CYGB and MT2A (|correlation coefficient (r)| > 0.3, p < 0.05). These key genes were functionally associated with antioxidant activity, toxic substance response, and inorganic compound detoxification, primarily involved in oxidative phosphorylation and Huntington’s disease-related pathways. Notably, ALOX15 and CAT were significantly correlated with activated dendritic cells and CD4 memory T cells. Drug prediction revealed 15 compounds targeting ALOX15, MT2A, and CAT. Expression of ALOX15, CAT, and HBZ was down-regulated, while MT2A and CYGB were up-regulated in the HLH group, consistent with differential expression trends. Conclusion: This study identified five validated key genes—ALOX15, CAT, HBZ, MT2A, and CYGB—offering new insights into HLH pathogenesis and potential therapeutic targets.

1 January 2024 in Oncology Research
Verified
Journal Article
Open access
PDF file
JZJie Zhao
Jie Zhao
XYXuantao Yang
Xuantao Yang
HZHaixi Zhang
Haixi Zhang
XGXuezhong Gu
Xuezhong Gu
Multiple myeloma (MM) is a hematological tumor with high mortality and recurrence rate. Carfilzomib is a new-generation proteasome inhibitor that is used as the first-line therapy for MM. However, the development of drug resistance is a pervasive obstacle to treating MM. Therefore, elucidating the drug resistance mechanisms is conducive to the formulation of novel therapeutic therapies. To elucidate the mechanisms of carfilzomib resistance, we retrieved the GSE78069 microarray dataset containing carfilzomib-resistant LP-1 MM cells and parental MM cells. Differential gene expression analyses revealed major alterations in the major histocompatibility complex (MHC) and cell adhesion molecules. The upregulation of the tumor necrosis factor (TNF) receptor superfamily member 1A (TNFRSF1A) gene was accompanied by the downregulation of MHC genes and cell adhesion molecules. Furthermore, to investigate the roles of these genes, we established a carfilzomib-resistant cell model and observed that carfilzomib resistance induced TNFRSF1A overexpression and TNFRSF1A silencing reversed carfilzomib resistance and reactivated the expression of cell adhesion molecules. Furthermore, TNFRSF1A silencing suppressed the tumorigenesis of MM cells in immunocompetent mice, indicating that TNFRSF1A may lead to carfilzomib resistance by dampening antitumor immunity. Furthermore, our results indicated that TNFRSF1A overexpression conferred carfilzomib resistance in MM cells and suppressed the expression of MHC genes and cell adhesion molecules. The suppression of MHC genes and cell adhesion molecules may impair the interaction between immune cells and cancer cells to impair antitumor immunity. Future studies are warranted to further investigate the signaling pathway underlying the regulatory role of TNFRSF1A in MM cells.

1 April 2023
Verified
Journal Article
Closed access
YLYating Lin
Yating Lin
JHJun He
Jun He
FLFan Li
Fan Li
XGXuezhong Gu
Xuezhong Gu